Skip to main content
. 2022 Jul 21;11(14):4233. doi: 10.3390/jcm11144233

Table 6.

Changes in lung ultrasound (LUS) models during the different subsequent controls (T0, T1, T2 and T3), and changes in treatments offered. HFNC: high flow nasal cannulae. nCPAP: nasal Continuous Positive Airway Pressure.

TO T1 T2 T3 p Value
CASES (n = 185) Mild Bronchilitis (n = 129),69.7% Moderate/Severe Bronchiolitis (n = 56), 30.3% CASI (n = 185) Mild bronchilitis (n = 136), 73.5% Moderate/severe Bronchiolitis (n = 49), 26.5% CASES (n = 185) Mild Bronchiolitis (n = 152), 82.2% Moderate/Severe Bronchiolitis
(n = 33),
17.8%
CASES (n = 185) Mild bronchilitis
(n = 177), 95.7%
Moderate/severe Bronchiolitis (n = 8), 4.3%
LUNG ULTRASOUND MODELS
LUS MODELS
LUS + 148 (80%) 95 (73.6%) 53 (94.6%) 148 (80%) 100 (73.5%) 48
(98%)
142 (76.8%) 109 (71.7%) 33
(100%)
98 (53%) 91
(51.4%)
7 (87.5%) <0.001
LUS PATTERNS NORMAL 37 (20%) 34 (26.4%) 3 (5.4%) 37 (20%) 36 (26.5%) 1 (2.0%) 43 (23.2%) 43 (28.3%) 0 87 (47%) 86 (48.6%) 1
(12.5%)
<0.001
INTESTITIAL 14 (7.6%) 12 (9.3%) 2
(3.6%)
16 (8.6%) 15
(11%)
1
(2%)
19 (10.3%) 15
(9.9%)
4
(12.1%)
20 (10.8%) 18
(10.2 %)
2
(25%)
CONSOLIDATIVE 46 (24.9%) 32 (24.8%) 14 (25.0%) 40 (21.6%) 28 (20.6%) 12
(24.5%)
44
(23.8%)
37 (24.3%) 7
(21.2%)
43 (23.2%) 40 (22.6%) 3
(37.5%)
MIXED 88 (47.6%) 51 (39.5%) 37 (66.1%) 92 (49.7%) 57 (41.9%) 35 (71.4%) 79 (0.427%) 57 (0.375%) 22 (0.667%) 35 (0.189%) 33 (0.186) 2 (0.25%)
SCORE,
mean ± SD
9.5 ± 5.2 8.0 ± 4.4 13.2 ± 5.0 10.0 ± 5.9 8.3 ± 5.1 14.8 ± 5.7 8.8 ± 5.1 7.7 ± 4.6 13.6 ± 4.5 6.2 ± 4.5 6.0 ± 4.4 10.5 ± 5.8 <0.001
Score > 9 85 (45.9%) 39 (30.2%) 46 (82.1%) 93 (50.3%) 52 (38.2%) 41
(83.7%)
72 (38.9%) 45 (29.6%) 27
(81.8%)
40 (21.6%) 35 (19.8%) 5
(62.5%)
<0.001
Extension ± SD 2.3 ± 1.8 1.8 ± 1.6 3.4 ± 1.8 2.5 ± 2.0 1.9 ± 1.8 4.1 ± 1.8 2.1 ± 1.8 1.8 ± 1.6 3.6 ± 1.6 1.2 ± 1.5 1.1 ± 1.4 2.9 ± 2.0 <0.001